28^th Annual Spring
Congress

Given the rapidly emerging popularity surrounding legalization in the United States, thousands of healthcare providers and clinicians live in geographical areas in which marijuana is legalized. More recently, an October 2018 survey conducted by Pew Research Center indicates that a growing number of Americans support marijuana legalization, with the 62% polled reflecting a steady increase over the past decade.

Healthcare practitioners receive daily questions from patients regarding medical Phytocannabinoids, yet most remain unequipped to answer any specific queries—given the lack of education concerning clinical cannabis. Most clinicians have received little to no formal training on specific recommendations, dosage protocols, side effects, product quality, and potential drug interactions which are critical aspects of patient care.

This Cannabinoids workshop is designed to educate attendees—both the novices and regular prescribers on a variety of related topics, based on the latest scientific evidence and clinical research. Primary topics incorporated through the workshop's sessions will include the major phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) found in marijuana and hemp plants. Given that both CBD and Δ9-THC and many others yield unique interactions with the body's endocannabinoid system (ECS), lectures will demonstrate the ways in which phytocannabinoids modulate & influence a variety of physiological systems: including appetite, pain, inflammation, thermoregulation, sensation, muscle control, energy balance, metabolism, sleep hygiene, stress responses, motivation/reward, mood, and memory.